Markets
EVH

Here's Why Evolent Health Jumped Higher Today

What happened

Shares of Evolent Health (NYSE: EVH) are up 20.4% at 3:23 p.m. EDT after the company announced that Passport Health Plan, one of Evolent Health's biggest customers, is being sold to Molina Healthcare (NYSE: MOH).

Last month, Evolent fell substantially after disclosing that Passport didn't get its Medicaid contract with the state of Kentucky renewed for 2021. The sale of Passport to Molina rescues some of Evolent's lost business and will put some money in the company's pockets since it had statutory capital tied up in the health plan.

Handshake

Image source: Getty Images.

So what

Molina's total payment for acquiring Passport is partially based on Passport's performance for the remainder of this year and how many members are retained when Molina takes over the contract in 2021. But based on current forecasts, Evolent expects to get between $130 million and $170 million when the deal is completed, which includes the repayment of a $40 million surplus note. Even at the low end of the estimate, that's not too shabby of a return considering that Evolent invested $110 million in Passport last year.

Starting in 2021, Evolent won't be doing as much for Molina's Kentucky Medicaid plan as it was doing for Passport. At this point, Molina has only retained Evolent to provide specialty care management services for cardiovascular care in Kentucky. But Molina is a much larger company than Passport, and management noted that there's a possibility that Molina may contract with Evolent to provide services for plans Molina runs in other states.

Now what

Evolent has certainly made lemonade out of the lemons that Kentucky's Medicaid program handed it. And the healthcare company could even end up coming out ahead if it can capture more of Molina's business. Beyond Molina, management has a goal of capturing six to eight new customer contracts this year, which should diversify its revenue stream and reduce the risk associated with relying on a few contracts for a bulk of its income.

10 stocks we like better than Evolent Health
When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor, has tripled the market.*

David and Tom just revealed what they believe are the ten best stocks for investors to buy right now... and Evolent Health wasn't one of them! That's right -- they think these 10 stocks are even better buys.

See the 10 stocks

 

*Stock Advisor returns as of June 2, 2020

 

Brian Orelli, PhD has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

EVH MOH

Latest Markets Videos

    The Motley Fool

    Founded in 1993 in Alexandria, VA., by brothers David and Tom Gardner, The Motley Fool is a multimedia financial-services company dedicated to building the world's greatest investment community. Reaching millions of people each month through its website, books, newspaper column, radio show, television appearances, and subscription newsletter services, The Motley Fool champions shareholder values and advocates tirelessly for the individual investor. The company's name was taken from Shakespeare, whose wise fools both instructed and amused, and could speak the truth to the king -- without getting their heads lopped off.

    Learn More